# Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial

> **NCT06438588** · NA · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 10 (estimated)

## Conditions studied

- Advanced Malignant Solid Neoplasm

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Dietary Intervention
- **OTHER:** Educational Intervention
- **OTHER:** Electronic Health Record Review
- **OTHER:** Interview
- **OTHER:** Nutritional Assessment
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT06438588
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-06
- **Primary completion:** 2027-03-15
- **Final completion:** 2027-03-15
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06438588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06438588, "Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06438588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*